These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15745164)

  • 1. [Amendment to the infectious disease control law].
    Okabe N
    Uirusu; 2004 Dec; 54(2):249-54. PubMed ID: 15745164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The new law concerning the prevention of infectious diseases and medical care for patients of infections].
    Satoh T
    Rinsho Byori; 2000 Jan; Suppl 111():181-6. PubMed ID: 10804810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tuberculosis Control Law of Japan: current issues and prospects of tuberculosis control plan].
    Tsukahara T
    Kekkaku; 2006 Dec; 81(12):737-43. PubMed ID: 17240919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reconsideration of the admission and discharge criteria of tuberculosis patients in Japan].
    Masuyama H; Igari H
    Kekkaku; 2013 Mar; 88(3):373-85. PubMed ID: 23672177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious disease-related laws: prevention and control measures.
    Park M
    Epidemiol Health; 2017; 39():e2017033. PubMed ID: 28774161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of communicable diseases. Interim final rule with comment period.
    Centers for Disease Control and Prevention (CDC), Public Health Service (PHS), Department of Health and Human Services (HHS)
    Fed Regist; 2003 Apr; 68(69):17558-60. PubMed ID: 12693414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The impact of the amendment to the Infectious Diseases Control Law on the management of clinical laboratories].
    Okuzumi K; Arakawa N; Kumasaka K
    Rinsho Byori; 2007 Jul; 55(7):671-7. PubMed ID: 17718063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging trends in international law concerning global infectious disease control.
    Fidler DP
    Emerg Infect Dis; 2003 Mar; 9(3):285-90. PubMed ID: 12643821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5. Infectious disease surveillance designated by the Infectious Disease Control Law, and the situation of emerging/re-emerging infectious diseases in Japan.
    Okabe N
    Intern Med; 2002 Jan; 41(1):61-2. PubMed ID: 11838598
    [No Abstract]   [Full Text] [Related]  

  • 12. [Communicable diseases law: new legislation for infectious disease control].
    Dute JC; van Wijngaarden JK
    Ned Tijdschr Geneeskd; 1999 May; 143(20):1049-53. PubMed ID: 10368733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globalization, international law, and emerging infectious diseases.
    Fidler DP
    Emerg Infect Dis; 1996; 2(2):77-84. PubMed ID: 8903206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of vaccination policy in Japan: current issues and policy directions.
    Nakatani H; Sano T; Iuchi T
    Jpn J Infect Dis; 2002 Aug; 55(4):101-11. PubMed ID: 12403906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of Global Infectious Disease Governance in 2000s: Rise of Global Health Security and Transformation of Infectious Disease Control System in South Korea.
    Choi EK; Lee JK
    Uisahak; 2016 Dec; 25(3):489-518. PubMed ID: 28529302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Communicable diseases defined in the new 'Infectious Diseases Prevention Law'].
    Yamazaki S
    Ryoikibetsu Shokogun Shirizu; 1999; (25 Pt 3):425-32. PubMed ID: 10337841
    [No Abstract]   [Full Text] [Related]  

  • 17. Infectious agents of bioterrorism: a review for emergency physicians.
    Kman NE; Nelson RN
    Emerg Med Clin North Am; 2008 May; 26(2):517-47, x-xi. PubMed ID: 18406986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of law in biopreparedness.
    Hodge JG
    Biosecur Bioterror; 2012 Mar; 10(1):38-48. PubMed ID: 22455677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Model State Emergency Health Powers Act: planning for and response to bioterrorism and naturally occurring infectious diseases.
    Gostin LO; Sapsin JW; Teret SP; Burris S; Mair JS; Hodge JG; Vernick JS
    JAMA; 2002 Aug; 288(5):622-8. PubMed ID: 12150674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A viewpoint of the revision of the prevention law of infectious diseases].
    Takeda Y
    Nihon Koshu Eisei Zasshi; 1998 Jul; 45(7):609-11. PubMed ID: 9757767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.